Benzo[1,3]dioxol-5-yl-piperazin-1-yl-Methanone hydrochloride
![]() |
- $395 - $1337
- Product name: Benzo[1,3]dioxol-5-yl-piperazin-1-yl-Methanone hydrochloride
- CAS: 1093402-61-9
- MF: C12H15ClN2O3
- MW: 270.71
- EINECS:
- MDL Number:MFCD10534024
- Synonyms:Benzo[1,3]dioxol-5-yl-piperazin-1-yl-Methanone hydrochloride;Benzo[d][1,3]dioxol-5-yl(piperazin-1-yl)Methanone hydrochloride;1-(2H-1,3-benzodioxole-5-carbonyl)piperazine hydrochloride
4 prices
Selected condition:
Brand
- AK Scientific
- Alichem
- Chemenu
Package
- 500mg
- 1g
- 10g
- ManufacturerAK Scientific
- Product number5471CX
- Product descriptionBenzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride
- Packaging500mg
- Price$395
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number5471CX
- Product descriptionBenzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride
- Packaging10g
- Price$1337
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1093402619
- Product descriptionBenzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM155182
- Product descriptionBenzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride 95%
- Packaging1g
- Price$405
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 5471CX | Benzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride | 500mg | $395 | 2021-12-16 | Buy |
AK Scientific | 5471CX | Benzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride | 10g | $1337 | 2021-12-16 | Buy |
Alichem | 1093402619 | Benzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride | 1g | $400 | 2021-12-16 | Buy |
Chemenu | CM155182 | Benzo[d][1,3]dioxol-5-yl(piperazin-1-yl)methanonehydrochloride 95% | 1g | $405 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|